U.S. Effort to Restrict Illicit Drugs Impacting our Nation at 'Bangkok III' Conference
At the February 21-24 ‘Bangkok III’ conference, the United States will seek to make progress in stopping the illegal trafficking of synthetic drugs, including fentanyl, that are harming U.S. communities. At this international meeting, convened by the United Nations Office on Drugs and Crime (UNODC) and the International Narcotics Control Board (INCB), the United States will partner with international organizations and other nations to restrict the illicit production and transnational trafficking of drugs.
At Bangkok III, we will seek enhanced control of the precursor chemicals used to make illicit fentanyl, a substance that is driving opioid-related overdoses in the United States. Harmful drugs classified as new psychoactive substances (NPS), which include fentanyl-like substances known as “fentanyl analogues”, will also be a focus area.
Ambassador Luis Arreaga, Principal Deputy Assistant Secretary of State for International Narcotics and Law Enforcement Affairs (INL), leads the interagency U.S. delegation at the conference. Law enforcement and drug control experts from the Departments of State, Justice, and the Drug Enforcement Agency (DEA) are also part of the U.S. delegation.
Beyond bilateral meetings to strengthen counternarcotics cooperation, the United States, Mexico, and Canada will lead a side event on our regional partnership against fentanyl trafficking. The event aims to raise awareness among the expert community of the need for more international coordination in the face of this inherently transnational challenge.
For more information about Bangkok III or INL, please contact INL-PAPD@state.gov or follow INL on Twitter at @StateINL.